English | Español

Federal Trade Commission
Patient Daily | Feb 10, 2026

Political commentator Emily Austin on PBMs: 'Hidden middlemen driving up drug prices'

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Palbociclib shows promise extending survival in HR+, HER2+ metastatic breast cancer